Results from a Randomized, Placebo-Controlled Clinical Trial of a RBX2660 - A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

Erik R. Dubberke, Christine H. Lee, Robert Orenstein, Sahil Khanna, Gail Hecht, Dale N. Gerding

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Results from a Randomized, Placebo-Controlled Clinical Trial of a RBX2660 - A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection'. Together they form a unique fingerprint.

Medicine & Life Sciences